Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 182

1.

Temporal Trends in Adoption and Outcomes of Transcatheter Aortic Valve Implantation: A Swisstavi Registry Analysis.

Stortecky S, Franzone A, Heg D, Tueller D, Noble S, Pilgrim T, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Muller O, Huber C, Roffi M, Carrel T, Wenaweser P, Windecker S.

Eur Heart J Qual Care Clin Outcomes. 2018 Oct 9. doi: 10.1093/ehjqcco/qcy048. [Epub ahead of print]

PMID:
30304513
2.

[The Old-Age Heart].

Attenhofer Jost C, Müller P, Bertel O, Naegeli B, Scharf C, Wenaweser P, Amann FW.

Praxis (Bern 1994). 2018 Aug;107(16):894-901. doi: 10.1024/1661-8157/a003039. German.

PMID:
30086692
3.

A Glimpse into the Future: In 2020, Which Patients will Undergo TAVI or SAVR?

O'Sullivan CJ, Wenaweser P.

Interv Cardiol. 2017 May;12(1):44-50. doi: 10.15420/icr.2016:24:2.

4.

Left ventricular afterload reduction by transcatheter aortic valve implantation in severe aortic stenosis and its prompt effects on comprehensive coronary haemodynamics.

Stoller M, Gloekler S, Zbinden R, Tueller D, Eberli F, Windecker S, Wenaweser P, Seiler C.

EuroIntervention. 2018 Jun 20;14(2):166-173. doi: 10.4244/EIJ-D-17-00719.

5.

Improvement of Risk Prediction After Transcatheter Aortic Valve Replacement by Combining Frailty With Conventional Risk Scores.

Schoenenberger AW, Moser A, Bertschi D, Wenaweser P, Windecker S, Carrel T, Stuck AE, Stortecky S.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):395-403. doi: 10.1016/j.jcin.2017.11.012.

PMID:
29471953
6.

Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement.

Asami M, Stortecky S, Praz F, Lanz J, Räber L, Franzone A, Piccolo R, Siontis GCM, Heg D, Valgimigli M, Wenaweser P, Roost E, Windecker S, Pilgrim T.

JACC Cardiovasc Imaging. 2018 Feb 14. pii: S1936-878X(18)30012-3. doi: 10.1016/j.jcmg.2017.12.015. [Epub ahead of print]

PMID:
29454762
7.

Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model.

Pilgrim T, Franzone A, Stortecky S, Nietlispach F, Haynes AG, Tueller D, Toggweiler S, Muller O, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M, Grünenfelder J, Huber C, Wenaweser P, Windecker S.

Circ Cardiovasc Interv. 2017 Nov;10(11). pii: e005481. doi: 10.1161/CIRCINTERVENTIONS.117.005481.

8.

Erratum to: Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.

Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, Linke A; ADVANCE Study Investigators.

Clin Res Cardiol. 2017 Oct;106(10):849. doi: 10.1007/s00392-017-1124-z. No abstract available.

PMID:
28676951
9.

Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.

Falk V, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Linke A, Ince H, Wenaweser P, Allocco DJ, Dawkins KD, Van Mieghem NM.

Eur Heart J. 2017 Dec 1;38(45):3359-3366. doi: 10.1093/eurheartj/ehx297.

PMID:
28651336
10.

Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study.

Gerckens U, Tamburino C, Bleiziffer S, Bosmans J, Wenaweser P, Brecker S, Guo J, Linke A.

Eur Heart J. 2017 Sep 21;38(36):2729-2738. doi: 10.1093/eurheartj/ehx295.

11.

Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohorts.

Franzone A, Stortecky S, Räber L, Heg D, Yamaji K, Piccolo R, Asami M, Lanz J, Praz F, Koskinas K, Zanchin T, Wenaweser P, Valgimigli M, Jüni P, Pilgrim T, Windecker S.

Int J Cardiol. 2017 Sep 15;243:150-155. doi: 10.1016/j.ijcard.2017.05.071. Epub 2017 May 17.

PMID:
28536005
12.

Switzerland: coronary and structural heart interventions from 2010 to 2015.

Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Röthlisberger C, Corti R, Rickli H, Kaiser C, Roffi M.

EuroIntervention. 2017 May 15;13(Z):Z75-Z79. doi: 10.4244/EIJ-D-16-00828.

13.

Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.

Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, Linke A; ADVANCE Study Investigators.

Clin Res Cardiol. 2017 Oct;106(10):784-795. doi: 10.1007/s00392-017-1120-3. Epub 2017 May 8. Erratum in: Clin Res Cardiol. 2017 Jul 4;:.

PMID:
28484830
14.

Rates and predictors of hospital readmission after transcatheter aortic valve implantation.

Franzone A, Pilgrim T, Arnold N, Heg D, Langhammer B, Piccolo R, Roost E, Praz F, Räber L, Valgimigli M, Wenaweser P, Jüni P, Carrel T, Windecker S, Stortecky S.

Eur Heart J. 2017 Jul 21;38(28):2211-2217. doi: 10.1093/eurheartj/ehx182.

PMID:
28430920
15.

Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.

Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators.

N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17.

PMID:
28304219
16.

Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis.

Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Jüni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M.

EuroIntervention. 2017 Apr 7;12(18):e2170-e2176. doi: 10.4244/EIJ-D-16-00677.

17.

The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.

Vollenbroich R, Stortecky S, Praz F, Lanz J, Franzone A, Zuk K, Heg D, Valgimigli M, O'Sullivan CJ, Heinisch C, Roost E, Wenaweser P, Windecker S, Pilgrim T.

Am Heart J. 2017 Feb;184:71-80. doi: 10.1016/j.ahj.2016.10.015. Epub 2016 Oct 28.

PMID:
27892889
18.

Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.

Pilgrim T, Stortecky S, Nietlispach F, Heg D, Tueller D, Toggweiler S, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M, Grünenfelder J, Huber C, Wenaweser P, Windecker S.

J Am Heart Assoc. 2016 Nov 17;5(11). pii: e004088.

19.

Evolution of Cognitive Function After Transcatheter Aortic Valve Implantation.

Schoenenberger AW, Zuber C, Moser A, Zwahlen M, Wenaweser P, Windecker S, Carrel T, Stuck AE, Stortecky S.

Circ Cardiovasc Interv. 2016 Oct;9(10). pii: e003590. Epub 2016 Sep 21.

PMID:
27655999
20.

Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.

Koskinas KC, Shakir S, Fankhauser M, Nietlispach F, Attinger-Toller A, Moschovitis A, Wenaweser P, Pilgrim T, Stortecky S, Praz F, Räber L, Windecker S, Meier B, Gloekler S.

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1374-83. doi: 10.1016/j.jcin.2016.04.019.

Supplemental Content

Loading ...
Support Center